Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer?

Keyphrases

• Triple-negative Breast Cancer 100%
• Imaging Modalities 100%
• Response to Neoadjuvant Chemotherapy 100%
• Response Prediction 100%
• Neoadjuvant Chemotherapy 60%
• Residual Tumor Size 60%
• Tumor 40%
• Magnetic Resonance Imaging 40%
• Pathologic 40%
• Pathological Complete Response 40%
• Mammography 40%
• Residual Disease 40%
• Mammography Ultrasonography 40%
• Chemosensitive 20%
• Tumor Grade 20%
• Tumor Size 20%
• Surgical Intervention 20%
• Surgical Treatment 20%
• Invasive Disease 20%
• Chi-square Test 20%
• Breast Magnetic Resonance Imaging 20%
• Breast Ultrasonography 20%

Medicine and Dentistry

• Neoplasm 100%
• Neoadjuvant Chemotherapy 100%
• Triple Negative Breast Cancer 100%
• Mammography 66%
• Magnetic Resonance Imaging 50%
• Echography 50%
• Minimal Residual Disease 33%
• Surgery 33%
• Clinical Stage 16%
• Breast Ultrasound 16%
• Diseases 16%